DK1824493T3 - Oral suspension, der omfatter meloxicam - Google Patents

Oral suspension, der omfatter meloxicam

Info

Publication number: DK1824493T3
Authority: DK; Denmark
Prior art keywords: meloxicam; oral suspension; pain; acute; preparation
Prior art date: 2004-12-06

Application number

DK05850431T

Other languages

English (en)

Inventor

Caspar Peter Elisabeth Biesmans

Spiegeleer Bart De

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-06

Filing date

2005-12-02

Publication date

2008-12-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929998&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1824493(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-12-02 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2008-12-08 Application granted granted Critical

2008-12-08 Publication of DK1824493T3 publication Critical patent/DK1824493T3/da

Links

ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 title abstract 2
229960001929 meloxicam Drugs 0.000 title abstract 2
229940100692 oral suspension Drugs 0.000 title abstract 2
206010061218 Inflammation Diseases 0.000 abstract 1
208000023178 Musculoskeletal disease Diseases 0.000 abstract 1
230000001154 acute effect Effects 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

DK05850431T 2004-12-06 2005-12-02 Oral suspension, der omfatter meloxicam DK1824493T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04106318		2004-12-06
PCT/EP2005/056419 WO2006061351A1 (en)	2004-12-06	2005-12-02	Oral suspension comprising meloxicam

Publications (1)

Publication Number	Publication Date
DK1824493T3 true DK1824493T3 (da)	2008-12-08

Family

ID=34929998

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05850431T DK1824493T3 (da)	2004-12-06	2005-12-02	Oral suspension, der omfatter meloxicam

Country Status (14)

Country	Link
US (1)	US7705000B2 (da)
EP (1)	EP1824493B1 (da)
JP (1)	JP2008523024A (da)
AT (1)	ATE404206T1 (da)
AU (1)	AU2005313365A1 (da)
CA (1)	CA2586288A1 (da)
DE (1)	DE602005009016D1 (da)
DK (1)	DK1824493T3 (da)
ES (1)	ES2313452T3 (da)
NO (1)	NO20073419L (da)
PL (1)	PL1824493T3 (da)
PT (1)	PT1824493E (da)
TW (1)	TW200635598A (da)
WO (1)	WO2006061351A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1568369A1 (en)	2004-02-23	2005-08-31	Boehringer Ingelheim Vetmedica Gmbh	Use of meloxicam for the treatment of respiratory diseases in pigs
US8497258B2 (en)	2005-11-12	2013-07-30	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
GB2438287A (en) *	2006-05-19	2007-11-21	Norbrook Lab Ltd	Stable aqueous suspension
CA2645205C (en) *	2006-05-19	2012-12-04	Norbrook Laboratories Limited	Stable aqueous suspension having palatable taste
WO2008009664A2 (en) *	2006-07-19	2008-01-24	Boehringer Ingelheim International Gmbh	Treatment of pain
FR2911506B1 (fr) *	2007-01-18	2009-07-03	Ceva Sante Animale Sa	Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees
US8999395B2 (en)	2007-02-09	2015-04-07	Ceva Sante Animale	Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
US20150231156A1 (en) *	2007-11-13	2015-08-20	Meritage Pharma, Inc.	Corticosteroid compositions
EP2328585A4 (en) *	2008-09-05	2011-09-21	Troy Lab Pty Ltd	TREATMENT OF NEWBORN FOAL WITH MELOXICAM
MX389960B (es) *	2009-10-12	2025-03-20	Boehringer Ingelheim Vetmedica Gmbh	Recipientes para composiciones que comprenden meloxicam.
GB201006218D0 (en)	2010-04-14	2010-06-02	Ayanda As	Composition
GB201117858D0 (en) *	2011-10-17	2011-11-30	Norbrook Lab Ltd	Paste
PL239019B1 (pl) *	2017-07-14	2021-10-25	Aflofarm Farm Polska Spolka Z Ograniczona Odpowiedzialnoscia	Kompozycja farmaceutyczna w postaci wodnego roztworu, korzystnie syropu, zawierająca pranobeks inozyny oraz glukonianu cynku oraz jej sposób otrzymywania
TW201912148A (zh) *	2017-08-24	2019-04-01	大陸商江蘇恆瑞醫藥股份有限公司	一種包含美洛昔康的可注射的醫藥組成物及其製備方法
JP7374501B2 (ja) *	2018-05-11	2023-11-07	南京清普生物科技有限公司	メロキシカム組成物、製剤及びその製造方法と応用
EA202190045A1 (ru) *	2018-06-15	2021-03-17	Янссен Фармацевтика Нв	Составы/композиции, содержащие ибрутиниб
GB2585825B (en) *	2019-07-09	2023-03-22	Lexon Uk Holdings Ltd	Suspending vehicle formulation
KR102530032B1 (ko)	2019-09-18	2023-05-09	정원구	반려동물용 현탁액 조성물 및 이의 제조방법
CN113143863A (zh) *	2020-01-22	2021-07-23	浙江贝灵生物医药有限公司	一种口服溶媒组合物及其制备方法与应用
CN112587497A (zh) *	2020-12-25	2021-04-02	苏州中化药品工业有限公司	一种美洛昔康混悬液胶囊剂及其制备方法
CN115634198A (zh) *	2021-07-20	2023-01-24	浙江贝灵生物医药有限公司	用于水难溶性物质的溶媒组合物及其制备方法与应用
CN116327711B (zh) *	2022-01-18	2026-01-23	中国人民解放军军事科学院军事医学研究院	一种生物利用度高的美洛昔康纳米晶组合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ234143A (en) *	1989-06-28	1991-10-25	Mcneil Ppc Inc	Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5272137A (en) *	1992-02-14	1993-12-21	Mcneil-Pfc, Inc.	Aqueous pharmaceutical suspension for pharmaceutical actives
IT1286496B1 (it)	1996-11-20	1998-07-15	Leetrim Ltd Dublin	Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
AU750125B2 (en)	1997-08-27	2002-07-11	Hexal Ag	New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
EP0945134A1 (de)	1998-03-27	1999-09-29	Boehringer Ingelheim Pharma KG	Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
EP0945131A1 (de) *	1998-03-27	1999-09-29	Boehringer Ingelheim Pharma KG	Perorale Wirkstoff-Suspension
CN1175904C (zh) *	1998-05-15	2004-11-17	若素制药株式会社	抗炎滴眼剂
DE10030345A1 (de)	2000-06-20	2002-01-10	Boehringer Ingelheim Vetmed	Hochkonzentrierte stabile Meloxicamlösungen
EP2260837A1 (en) *	2001-06-01	2010-12-15	Pozen, Inc.	Pharmaceutical compositions for the coordinated delivery of NSAIDs
US7666876B2 (en) *	2002-03-19	2010-02-23	Vernalis (R&D) Limited	Buprenorphine formulations for intranasal delivery
JP2004131495A (ja) *	2002-09-17	2004-04-30	Nippon Boehringer Ingelheim Co Ltd	非ステロイド系抗炎症剤の局所送達用医薬組成物
US20050095299A1 (en) *	2003-10-30	2005-05-05	Wynn David W.	Controlled release analgesic suspensions

2005
- 2005-12-02 ES ES05850431T patent/ES2313452T3/es not_active Expired - Lifetime
- 2005-12-02 PL PL05850431T patent/PL1824493T3/pl unknown
- 2005-12-02 US US11/720,869 patent/US7705000B2/en not_active Expired - Fee Related
- 2005-12-02 DK DK05850431T patent/DK1824493T3/da active
- 2005-12-02 EP EP05850431A patent/EP1824493B1/en not_active Revoked
- 2005-12-02 JP JP2007544887A patent/JP2008523024A/ja active Pending
- 2005-12-02 PT PT05850431T patent/PT1824493E/pt unknown
- 2005-12-02 AU AU2005313365A patent/AU2005313365A1/en not_active Abandoned
- 2005-12-02 DE DE602005009016T patent/DE602005009016D1/de not_active Expired - Lifetime
- 2005-12-02 CA CA002586288A patent/CA2586288A1/en not_active Abandoned
- 2005-12-02 WO PCT/EP2005/056419 patent/WO2006061351A1/en not_active Ceased
- 2005-12-02 AT AT05850431T patent/ATE404206T1/de active
- 2005-12-05 TW TW094142716A patent/TW200635598A/zh unknown
2007
- 2007-07-03 NO NO20073419A patent/NO20073419L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ES2313452T3 (es)	2009-03-01
EP1824493B1 (en)	2008-08-13
ATE404206T1 (de)	2008-08-15
NO20073419L (no)	2007-07-03
AU2005313365A1 (en)	2006-06-15
DE602005009016D1 (de)	2008-09-25
PL1824493T3 (pl)	2009-01-30
JP2008523024A (ja)	2008-07-03
TW200635598A (en)	2006-10-16
PT1824493E (pt)	2008-11-18
WO2006061351A1 (en)	2006-06-15
US20090221563A1 (en)	2009-09-03
CA2586288A1 (en)	2006-06-15
US7705000B2 (en)	2010-04-27
EP1824493A1 (en)	2007-08-29

Similar Documents

Publication	Publication Date	Title
NO20073419L (no)	2007-07-03	Oral suspensjon omfattende meloxikam
HRP20110969T1 (en)	2012-01-31	Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
MY143407A (en)	2011-05-13	Indazole derivatives as inhibitors of hormone sensitive lipase
IS8349A (is)	2006-03-13	2,4-pýrimídíndíamín gagnleg í meðhöndlun æxlissjúkdóma, bólgu- og ónæmiskerfissjúkdóma
CY1112320T1 (el)	2015-12-09	Τιτλοδοτηση της ταπενταδολης
DE602005017753D1 (de)	2009-12-31	Mittel für die transdermale verabreichung von nikotin
SI2262778T1 (sl)	2019-12-31	1-benzil-3-hidroksimetilindazolni derivati in njihova uporaba pri zdravljenju bolezni, na osnovi izražanja MCP-1, CXCR1 in P40
MX2007010560A (es)	2008-02-21	Roflumilast para el tratamiento de diabetes mellitus.
EE200400005A (et)	2004-02-16	Tablett, mis sisaldab vähemalt kahte eristatavat segmenti ning selle kasutamine
MY135829A (en)	2008-07-31	Analeptic and drug combinations
FR2945210B1 (fr)	2011-07-01	Combinaison antitumorale comprenant l'ave8062 et le sorafenib
MX2009011502A (es)	2009-11-09	Uso de 4-(nitrooxi)-butil-(s)-2-(6-metoxi-2-naftil)-propanoato para el tratamiento del dolor y la inflamacion.
TWI372047B (en)	2012-09-11	Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
HRP20050579B1 (hr)	2014-01-31	Nove sinergistiäśne kombinacije koje sadrže roflumilast i formoterol
EA200900575A1 (ru)	2009-10-30	Композиция, содержащая антагонист рецептора nk1 и ssri, для лечения шума в ушах и потери слуха
EA200801890A1 (ru)	2009-04-28	Средство для лечения шума в ушах
PL1865966T3 (pl)	2010-03-31	Zastosowanie niesteroidowych leków przeciwzapalnych do inhalacji w leczeniu ostrego i chronicznego zapalenia oskrzeli
WO2010129788A3 (en)	2011-02-24	Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders
WO2005113814A3 (en)	2006-02-16	Biomarkers of chronic pelvic pain syndrome
MXPA04000418A (es)	2004-03-18	Tratamiento de dolor cronico con 3-heterocicloxi- y -cicloalquiloxi-3-fenilpropanaminas.
MY150436A (en)	2014-01-30	1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
JO2666B1 (en)	2012-06-17	Use of Agomelatine in obtaining medicaments intented for the treatment of Bipolar disorders
NO20065473L (no)	2006-11-28	IL-6RL/IL-6-kimaerer for terapi av kjemoterapeutisk indusert perifer nevropati.
SE0300988D0 (sv)	2003-04-03	New use
ITFI20060002U1 (it)	2007-07-05	"onivades" sedia che si trasforma in tavolino e viceversa.